Lantern Pharma
Price & Volume
Stats
See more52W Range | $2.55-$6.11 |
Market Cap | $44.9M |
Shares Short | 459,566 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.78 |
News
See moreYahoo Finance • 8 days ago
Lantern Pharma Says Phase 1a Study Of LP-184 Met All Primary Endpoints In Advanced Solid Tumors
Yahoo Finance • 14 days ago
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Panna Sharma, CEO of AI-Driven Biotech Focused on Challenging & Rare Cancers, Lantern Pharma Inc. (LTRN)
Yahoo Finance • 2 months ago
Lantern Pharma completes Japanese enrollment in lung cancer trial
Yahoo Finance • 2 months ago
Lantern Pharma appoints Lee T. Schalop, M.D. to board and amends quorum rules
About
CEO | Mr. Panna Sharma |
CFO | Mr. David R. Margrave |
Address | 1920 McKinney Avenue, Dallas, TX, United States, 75201 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 24 |
